Pharma-Bio Serv (PBSV) Gross Margin (2016 - 2025)
Historic Gross Margin for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to 34.84%.
- Pharma-Bio Serv's Gross Margin rose 37000.0% to 34.84% in Q4 2025 from the same period last year, while for Oct 2025 it was 32.33%, marking a year-over-year increase of 58700.0%. This contributed to the annual value of 32.33% for FY2025, which is 58700.0% up from last year.
- Pharma-Bio Serv's Gross Margin amounted to 34.84% in Q4 2025, which was up 37000.0% from 29.25% recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's Gross Margin ranged from a high of 34.84% in Q4 2025 and a low of 22.5% during Q1 2024
- For the 5-year period, Pharma-Bio Serv's Gross Margin averaged around 28.05%, with its median value being 27.13% (2021).
- Its Gross Margin has fluctuated over the past 5 years, first plummeted by -75900bps in 2024, then skyrocketed by 85800bps in 2025.
- Quarter analysis of 5 years shows Pharma-Bio Serv's Gross Margin stood at 26.78% in 2021, then dropped by -11bps to 23.9% in 2022, then increased by 8bps to 25.84% in 2023, then rose by 21bps to 31.14% in 2024, then rose by 12bps to 34.84% in 2025.
- Its Gross Margin was 34.84% in Q4 2025, compared to 29.25% in Q3 2025 and 33.87% in Q2 2025.